Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trialAxel Bauer, Uwe Dorwarth, Herbert Tilg et al.|The Lancet Respiratory Medicine|2021Cited by 104
Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammationKami Pekayvaz, Konstantin Stark, Christoph Gold et al.|Immunity|2023Cited by 42